About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Acetaminophen-Protein Adduct Resolution

Acetaminophen-Protein Adduct Resolution

NCT01021410·2 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Denver Health and Hospital Authority

With

McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Age

18–any

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Any subject randomized to the acetaminophen arm of COMIRB 06-1265 and meets completion criteria

You may not be if

Subjects who enter the extended dosing period in protocol 06-1265.
Subjects who were randomized to placebo.

The record

StatusCompleted

PhaseNo phase

Taking part100

StartedNov 2009

UpdatedAug 8, 2012

Conditions

Acetaminophen-protein Adduct Formation

Where2

University of Colorado Hospital CTRC
Aurora, Colorado, United States
Denver Health and Hospital Authority
Denver, Colorado, United States